Grenova – a Virginia-based sustainable laboratory technologies company – announced two significant milestones for the company: the appointment of Ted Hull to Grenova’s board, and the completion of a new round of growth equity capital. The funding was led by Grenova investors, Peloton Equity and Hamilton Lane’s Impact Fund II, along with other existing investors.
These changes support Grenova’s strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide.
What the funding will be used for: The funding will enhance Grenova’s automation portfolio, expand R&D capabilities, and grow the team to meet rising demand across global markets.
Ted Hull’s background: Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Hull is set to provide strategic leadership and to play a pivotal role in shaping the company’s future.
KEY QUOTES:
“I am honored to join Grenova at such an exciting time in the company’s journey. Grenova is revolutionizing the way laboratories think about and use plastics—transforming single-use mindsets into sustainable, reusable solutions. I look forward to working closely with this talented team to continue driving meaningful change.”
Ted Hull
“This investment affirms confidence in our vision and the market’s urgency to reduce plastic waste. With this capital and Ted Hull on the board, we’re positioned to accelerate our mission to scale sustainable lab practices.”
Katherine Marrs, CEO of Grenova
“We are excited to continue supporting Grenova’s growth. We have worked with Ted Hull over the past 20 years and are thrilled to have him join Grenova. Ted brings a powerful blend of vision and experience that will help Grenova press its advantage as a category leader.”
Ted Lundberg, Peloton Equity Managing Partner and Grenova’s Chairman
